Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 3 | 2023 | 255 | 1.330 |
Why?
|
| Neoplasms | 3 | 2022 | 438 | 1.320 |
Why?
|
| Precision Medicine | 1 | 2023 | 28 | 0.850 |
Why?
|
| Health Expenditures | 2 | 2021 | 75 | 0.740 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 201 | 0.730 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2020 | 2 | 0.720 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 5 | 0.720 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 262 | 0.720 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 289 | 0.720 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 44 | 0.680 |
Why?
|
| Physicians | 1 | 2021 | 137 | 0.670 |
Why?
|
| Patient Discharge | 2 | 2017 | 154 | 0.590 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 17 | 0.580 |
Why?
|
| Appointments and Schedules | 2 | 2013 | 26 | 0.520 |
Why?
|
| Humans | 16 | 2023 | 17611 | 0.510 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2013 | 15 | 0.430 |
Why?
|
| Patient Admission | 1 | 2013 | 72 | 0.420 |
Why?
|
| Length of Stay | 4 | 2017 | 181 | 0.420 |
Why?
|
| Critical Care | 1 | 2013 | 71 | 0.410 |
Why?
|
| Delivery of Health Care | 3 | 2020 | 415 | 0.390 |
Why?
|
| Pandemics | 2 | 2022 | 287 | 0.360 |
Why?
|
| Hospitals, Pediatric | 3 | 2013 | 79 | 0.280 |
Why?
|
| Prospective Studies | 2 | 2022 | 1267 | 0.260 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 1309 | 0.240 |
Why?
|
| Male | 3 | 2023 | 10008 | 0.230 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 1 | 0.220 |
Why?
|
| Cystitis, Interstitial | 1 | 2023 | 1 | 0.220 |
Why?
|
| Cost Sharing | 1 | 2023 | 30 | 0.210 |
Why?
|
| Research Report | 1 | 2022 | 22 | 0.210 |
Why?
|
| Child | 3 | 2022 | 2474 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 50 | 0.210 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2022 | 93 | 0.200 |
Why?
|
| Insurance Coverage | 1 | 2023 | 106 | 0.200 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 130 | 0.200 |
Why?
|
| Smoke | 1 | 2022 | 6 | 0.200 |
Why?
|
| Maternal Health Services | 1 | 2022 | 12 | 0.200 |
Why?
|
| Mentoring | 1 | 2022 | 26 | 0.190 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 6 | 0.180 |
Why?
|
| Cost of Illness | 1 | 2021 | 92 | 0.180 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 31 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 37 | 0.180 |
Why?
|
| Nephrologists | 1 | 2019 | 1 | 0.170 |
Why?
|
| Disease Management | 1 | 2020 | 135 | 0.170 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 142 | 0.160 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 325 | 0.160 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 53 | 0.160 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 72 | 0.160 |
Why?
|
| Aged | 4 | 2023 | 6095 | 0.160 |
Why?
|
| Incidence | 1 | 2022 | 1255 | 0.150 |
Why?
|
| Female | 3 | 2022 | 12608 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 4 | 0.150 |
Why?
|
| Medical Staff, Hospital | 1 | 2017 | 7 | 0.140 |
Why?
|
| Treatment Outcome | 1 | 2020 | 1259 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2017 | 113 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2017 | 305 | 0.130 |
Why?
|
| Risk Factors | 2 | 2022 | 3325 | 0.130 |
Why?
|
| Time Factors | 2 | 2017 | 1086 | 0.130 |
Why?
|
| Young Adult | 1 | 2022 | 2427 | 0.130 |
Why?
|
| Adolescent | 1 | 2022 | 3651 | 0.120 |
Why?
|
| United States | 5 | 2023 | 3956 | 0.110 |
Why?
|
| Pennsylvania | 1 | 2013 | 25 | 0.110 |
Why?
|
| Hospital Bed Capacity | 1 | 2012 | 7 | 0.100 |
Why?
|
| Bed Occupancy | 1 | 2010 | 1 | 0.090 |
Why?
|
| Medicare | 2 | 2023 | 202 | 0.090 |
Why?
|
| Middle Aged | 1 | 2021 | 7911 | 0.080 |
Why?
|
| Adult | 1 | 2021 | 7598 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2013 | 2447 | 0.080 |
Why?
|
| Neoplasm, Residual | 1 | 2023 | 5 | 0.060 |
Why?
|
| Policy | 1 | 2023 | 18 | 0.050 |
Why?
|
| Pelvic Pain | 1 | 2023 | 3 | 0.050 |
Why?
|
| Cystoscopy | 1 | 2023 | 4 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2023 | 9 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 41 | 0.050 |
Why?
|
| India | 1 | 2022 | 13 | 0.050 |
Why?
|
| Parturition | 1 | 2022 | 9 | 0.050 |
Why?
|
| Checklist | 1 | 2022 | 15 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2022 | 16 | 0.050 |
Why?
|
| Vascular Access Devices | 1 | 2019 | 1 | 0.040 |
Why?
|
| Preferred Provider Organizations | 1 | 2019 | 2 | 0.040 |
Why?
|
| Professional Practice | 1 | 2019 | 16 | 0.040 |
Why?
|
| Cost Savings | 1 | 2019 | 23 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 33 | 0.040 |
Why?
|
| Patients | 1 | 2019 | 34 | 0.040 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2020 | 42 | 0.040 |
Why?
|
| Self-Management | 1 | 2019 | 28 | 0.040 |
Why?
|
| Office Visits | 1 | 2019 | 80 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 86 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 211 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2019 | 189 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2019 | 228 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1322 | 0.040 |
Why?
|
| Pregnancy | 1 | 2022 | 1494 | 0.030 |
Why?
|
| Crowding | 1 | 2012 | 2 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2012 | 12 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 52 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 93 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2012 | 263 | 0.020 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->